Sato M - Search Results

1

Impact of visceral fat area in patients with chronic kidney disease.

Manabe S, Kataoka H, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K, Watanabe K, Watanabe S, Akihisa T, Makabe S, Sato M, Iwasa N, Yoshida R, Sawara Y, Hanafusa N, Tsuchiya K, Nitta K. Manabe S, et al. Among authors: sato m. Clin Exp Nephrol. 2021 Jun;25(6):608-620. doi: 10.1007/s10157-021-02029-4. Epub 2021 Feb 17. Clin Exp Nephrol. 2021. PMID: 33595731

2

Psoas abscess in hemodialysis patients.

Sato M, Iwasa Y, Otsubo S, Kimata N, Takei T, Miwa N, Akiba T, Nitta K. Sato M, et al. Int Urol Nephrol. 2010 Dec;42(4):1113-6. doi: 10.1007/s11255-009-9656-4. Epub 2009 Oct 4. Int Urol Nephrol. 2010. PMID: 19802728

3

Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters.

Kataoka H, Ohara M, Shibui K, Sato M, Suzuki T, Amemiya N, Watanabe Y, Honda K, Mochizuki T, Nitta K. Kataoka H, et al. Among authors: sato m. Clin Exp Nephrol. 2012 Oct;16(5):706-12. doi: 10.1007/s10157-012-0613-7. Epub 2012 Feb 17. Clin Exp Nephrol. 2012. PMID: 22350469

4

Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients.

Ogawa T, Kyono A, Sato M, Sugimoto H, Otsuka K, Nitta K. Ogawa T, et al. Among authors: sato m. Clin Exp Nephrol. 2012 Oct;16(5):779-85. doi: 10.1007/s10157-012-0626-2. Epub 2012 Mar 29. Clin Exp Nephrol. 2012. PMID: 22457088

5

Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patients.

Sato M, Ogawa T, Sugimoto H, Otsuka K, Nitta K. Sato M, et al. Intern Med. 2012;51(16):2111-7. doi: 10.2169/internalmedicine.51.8044. Epub 2012 Aug 15. Intern Med. 2012. PMID: 22892487 Free article.

6

Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patients.

Sato M, Ogawa T, Otsuka K, Ando Y, Nitta K. Sato M, et al. Clin Exp Nephrol. 2013 Apr;17(2):268-74. doi: 10.1007/s10157-012-0674-7. Epub 2012 Aug 2. Clin Exp Nephrol. 2013. PMID: 23011291

7

Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.

Ogawa T, Shimizu H, Kyono A, Sato M, Yamashita T, Otsuka K, Nitta K. Ogawa T, et al. Among authors: sato m. Int Urol Nephrol. 2014 Jan;46(1):151-9. doi: 10.1007/s11255-013-0494-z. Epub 2013 Jun 27. Int Urol Nephrol. 2014. PMID: 23807369

8

High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.

Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K. Moriyama T, et al. Among authors: sato m. J Nephrol. 2015 Aug;28(4):451-6. doi: 10.1007/s40620-014-0154-0. Epub 2014 Oct 30. J Nephrol. 2015. PMID: 25355499

9

Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.

Kawaguchi K, Kawanishi K, Sato M, Itabashi M, Fujii A, Kanetsuna Y, Huchinoue S, Ohashi R, Koike J, Honda K, Nagashima Y, Nitta K. Kawaguchi K, et al. Among authors: sato m. Nephrology (Carlton). 2015 Jul;20 Suppl 2:61-5. doi: 10.1111/nep.12465. Nephrology (Carlton). 2015. PMID: 26031589

10

Long-term outcomes of initial therapy for idiopathic membranous nephropathy.

Sato M, Takei T, Moriyama T, Itabashi M, Nitta K. Sato M, et al. Clin Exp Nephrol. 2017 Oct;21(5):842-851. doi: 10.1007/s10157-016-1371-8. Epub 2016 Dec 20. Clin Exp Nephrol. 2017. PMID: 27999961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,198 results

Search Page

Filters